has received contract grant funding from Acadia Pharmaceuticals, Lundbeck, Takeda and Axovant pharmaceutical companies, as well as honoraria from Lundbeck, Lilly, Otsuka and Orion pharmaceutical companies
GLP-1 treatments have shown promising results in helping people with obesity and type 2 diabetes slim down and improve their metabolic health
Beta-Glucan: Enhances hydration and supports the skin barrier
Other Ingredients: 98% L-carnitine tartrate, bulking agent microcrystalline cellulose, anti-caking agent magnesium stearate, capsule (gelatine, colour: E171)
Patients may benefit from synergistic GLP-1 and GIP receptor activation, though individual response depends on genetic variation in peptide receptor sensitivity
Wegovy, Oral Wegovy, Zepbound, and Foundayo, all FDA-approved for weight management, are available through Klinic